M.D. Anderson Cancer Center: Neoplasms trials

The registry lists 278 Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 35 are open to participants now and 54 have results posted.

Early Phase 1 7Phase 1 102Phase 2 62Phase 3 16Phase 4 4No phase 106(a study in two phases counts in both)

Studies

Page 2 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic MelanomaActive, not recruitingNCT05470283Phase 1
• A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)CompletedNCT05466994Phase 2
• Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and CaregiversActive, not recruitingNCT05436327Not applicable
• Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaActive, not recruitingNCT05394337Phase 1/2
• POWER UP: Participating Online While Exercising to Recover Using PlayTerminatedNCT05308407Not applicable
• Barriers and Facilitators in Access to OT/PT in Pediatric Cancer SurvivorsActive, not recruitingNCT05305950
• A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal AdenocarcinomaCompletedNCT05273554Phase 1
• 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic RadiosurgeryCompletedNCT05174026Not applicable
• Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA StudyWithdrawnNCT05169151
• Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic DevicesActive, not recruitingNCT05124405Not applicable
• Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative ChemotherapyCompletedNCT05083338
• Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General AnesthesiaCompletedNCT05060328
• Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerCompletedNCT05058339
• Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer PatientsTerminatedNCT05056831Not applicable
• Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain MetastasesCompletedNCT05054998Phase 4
• Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at WorkWithdrawnNCT05038384
• BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid TumorsWithdrawnNCT05010096Phase 1
• Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyWithdrawnNCT04987281Phase 2
• Viral Specific T Cell Therapy for COVID-19 Related PneumoniaCompletedNCT04742595Early Phase 1
• SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIALTerminatedNCT04729725Phase 1
• Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID StudyCompletedNCT04652505
• Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
• Perioperative Care in the Cancer Patient -1, ARCA-1 StudyCompletedNCT04491409
• Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic PainCompletedNCT04239976Not applicable
• Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care SettingsCompletedNCT04186884
• Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph NodesCompletedNCT04185337Early Phase 1
• Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral NeuropathyWithdrawnNCT04135326Early Phase 1
• Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain LesionsCompletedNCT04132843Not applicable
• Financial Distress in Advanced Cancer PatientsActive, not recruitingNCT04053517
• PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT04022785Phase 1
• Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid PrescriptionsStatus unknownNCT03989128
• New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image QualityCompletedNCT03980535Not applicable
• Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing PleuroscopyCompletedNCT03868579Not applicable
• Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic VisitsCompletedNCT03856060Not applicable
• Effectiveness of an Online Intervention Targeting Cancer-related FatigueTerminatedNCT03809130Not applicable
• A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
• TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT03756818Phase 1
• Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain MetastasesActive, not recruitingNCT03741673Phase 3
• DECT in Imaging Patients With Solid Organ Cancer With Intracranial MetastasisCompletedNCT03685539Not applicable
• Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit SmokingWithdrawnNCT03668769Not applicable
• Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With CancerCompletedNCT03656224
• Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced CancerWithdrawnNCT03592459Not applicable
• Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell CancerCompletedNCT03575949Not applicable
• Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral BronchoscopyCompletedNCT03523689
• Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
• Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With CancerCompletedNCT03445572Not applicable
• Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
• A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer CenterCompletedNCT03390283
• Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With CancerCompletedNCT03360799
• IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
• Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple MyelomaWithdrawnNCT03283046Phase 1
• rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin ChemotherapyActive, not recruitingNCT03219502Not applicable
• Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT03207542Phase 2
• Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell LymphomasWithdrawnNCT03205891Phase 1
• Oral Supplementation to Enhance Recovery Pilot StudyCompletedNCT03204266Early Phase 1
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic CancerTerminatedNCT03203525Phase 1
• The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) SymptomsWithdrawnNCT03177681Not applicable
• Effect of Physician Attire on Patients' Preference of PhysicianCompletedNCT03168763Not applicable
• Pneumoperitoneum Management With Low vs. Higher PressureWithdrawnNCT03128281Phase 2
• Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in ChildrenWithdrawnNCT03111069Phase 1
• Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaActive, not recruitingNCT03068624Phase 1
• Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)Status unknownNCT03053999
• Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological BehaviorCompletedNCT03046524
• Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care ClinicCompletedNCT03043378
• Wearable Exercise Trackers in Cancer RehabilitationCompletedNCT03042884Not applicable
• Communication Strategies to Introduce Psychology ServicesCompletedNCT03035448Not applicable
• Neoadjuvant Listeria or Daratumumab in Prostate CancerWithdrawnNCT03035357Phase 2
• Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory CancersCompletedNCT03017833Phase 1
• MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03004105Phase 2
• 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedNCT03001349Early Phase 1
• Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial DistressActive, not recruitingNCT02988271Not applicable
• Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care VisitCompletedNCT02957565Not applicable
• Study of Ixazomib and Erlotinib in Solid TumorsCompletedNCT02942095Phase 1
• Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
• Expectations Regarding Mobility and Self-CareActive, not recruitingNCT02911064
• Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated MalignanciesWithdrawnNCT02812056Phase 1
• Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain MetastasesCompletedNCT02798029Phase 2
• Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT02718755Phase 2
• Evaluation of Satisfaction With Quality of Care on the Palliative Care UnitCompletedNCT02686411
• Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-CompletionCompletedNCT02523378Not applicable
• Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational InterventionCompletedNCT02422329Not applicable
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
• Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerCompletedNCT02389751Phase 1
• Web-Based Family Outreach Program for Cancer Prevention in High-Risk FamiliesActive, not recruitingNCT02337452
• Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA GenesActive, not recruitingNCT02286687Phase 2
• Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer PatientsStatus unknownNCT02160366
• Regorafenib and Cetuximab in Patients With Advanced MalignancyCompletedNCT02095054Phase 1
• MLN9708 and Vorinostat in Patients With Advanced p53 Mutant MalignanciesCompletedNCT02042989Phase 1
• Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural MalignancyCompletedNCT01998529Phase 1
• Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyCompletedNCT01970254
• STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainCompletedNCT01904123Phase 1
• Ipilimumab and Lenalidomide in Advanced CancerCompletedNCT01750983Phase 1
• Dasatinib and Crizotinib in Advanced CancerCompletedNCT01744652Phase 1
• Ipilimumab and Imatinib Mesylate in Advanced CancerCompletedNCT01738139Phase 1
• Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot StudyCompletedNCT01737671Early Phase 1
• Magnetic Resonance Imaging of Gynecologic Malignancies Involving the VaginaCompletedNCT01703195Not applicable
• Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced CancersCompletedNCT01624766Phase 1
• Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced CancerCompletedNCT01596140Phase 1
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
• Pazopanib or Pemetrexed and Crizotinib in Advanced CancerTerminatedNCT01548144Phase 1